【摘要】 目的:探讨岩舒注射液雾化吸入辅助治疗晚期NSCLC(非小细胞肺癌)的临床疗效。方法:将369例晚期NSCLC患者随机分成治疗组和对照组,治疗组采用岩舒(复方苦参)注射液雾化吸入和NP方案联合化疗,对照组采取单纯NP方案化疗。化疗结束观察两组患者毒副反应、生存期、KPS评分、肿块大小变化等指标。结果:两组患者毒副反应、生存期、KPS评分、肿块大小变化比较差异有统计学意义(P<0.01)。结论:岩舒注射液雾化吸入联合NP方案化疗对晚期NSCLC患者有显著疗效,值得临床推广应用。更多还原

【Abstract】 Objective:To study the clinical effect of Yanshu injection nebulization as an adjuvant for advanced NSCLC(non-small cell lung cancer).Method:369 cases of advanced NSCLC patients were devided into therapy group and control group on random.The therapy group were given Yanshu injection combined NP program.The control group were given chemotherapy of NP program only.We observed side effect,lifetime,KPS score improvement and bump size after chemotherapy.Result:The aspects of side effect,lifetime,KPS score improvement and bump size have statistical significance(P<0.01).Conclusion:Yanshu injection nebulization combined NP program have significant effect on advanced NSCLC.It’s worth to be popularized in clinical treatment.更多还原